ENTO logo

Entero Therapeutics (ENTO) Cash From Investing

Annual CFI

-$500.00 K
-$500.00 K-100.00%

December 31, 2023

Summary

Performance

1-Year Change

-100%

3-Year Change

-672.74%

5-Year Change

-63.67%

15-Year Change

-1452.8%

ENTO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.35%
ENTO annual cash flow from investing activities is higher than 48.35% of companies in Healthcare sector

High & Low

All-time High

$87.30 K
ENTO annual cash flow from investing activities is currently -672.74% below its historical high of $87.30 thousand

3-Year Low

-$10.32 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ENTO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

May 14, 2025
ENTO next annual earnings announcement is scheduled for May 14, 2025

OtherENTOcash flowmetrics:

Annual CFF

$15.23 M
ENTO annual cash flow from financing activities is $15.23 million

Annual CFO

-$12.38 M
ENTO annual cash flow from operations is -$12.38 million

Annual FCF

-$12.88 M
ENTO annual free cash flow is -$12.88 million

Annual CAPEX

-
ENTO annual capital expenditures value is unknown

Quarterly CFI

$0.00
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+100%

3-Year Change

0%

5-Year Change

+100%

ENTO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.16%
ENTO quarterly cash flow from investing activities is higher than 68.16% of companies in Healthcare sector

High & Low

All-time High

$90.20 K
ENTO quarterly cash flow from investing activities is currently -100.00% below its historical high of $90.20 thousand

3-Year Low

-$10.25 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ENTO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 14, 2025
ENTO next earnings announcement is scheduled for May 14, 2025

OtherENTOcash flowmetrics:

Quarterly CFF

$1.55 M
ENTO quarterly cash flow from financing activities is $1.55 million

Quarterly CFO

-$1.85 M
ENTO quarterly cash flow from operations is -$1.85 million

Quarterly FCF

-$1.85 M
ENTO quarterly free cash flow is -$1.85 million

Quarterly CAPEX

-
ENTO quarterly capital expenditures value is unknown

TTM CFI

-$411.80 K
$0.000.00%

September 1, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+17.64%

3-Year Change

-100%

5-Year Change

-2627.15%

ENTO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.59%
ENTO TTM cash flow from investing activities is higher than 49.59% of companies in Healthcare sector

High & Low

All-time High

$87.40 K
ENTO TTM cash flow from investing activities is currently -571.17% below its historical high of $87.40 thousand

3-Year Low

-$10.32 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
ENTO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

May 14, 2025
ENTO next earnings announcement is scheduled for May 14, 2025

OtherENTOcash flowmetrics:

TTM CFF

$9.97 M
ENTO TTM cash flow from financing activities is $9.97 million

TTM CFO

-$12.49 M
ENTO TTM cash flow from operations is -$12.49 million

TTM FCF

-$12.49 M
ENTO TTM free cash flow is -$12.49 million

TTM CAPEX

-
ENTO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ENTO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%+100.0%+17.6%
3 y3 years-672.7%0.0%-100.0%
5 y5 years-63.7%+100.0%-2627.2%

ENTO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year<-9999.0%+95.2%-100.0%+100.0%<-9999.0%+96.0%
5 y5-year-672.7%+95.2%-100.0%+100.0%-571.2%+96.0%
alltimeall time-672.7%+95.2%-100.0%+100.0%-571.2%+96.0%

Entero Therapeutics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
-$411.80 K(0.0%)
Jun 2024
-
$0.00(-100.0%)
-$411.80 K(0.0%)
Mar 2024
-
$88.20 K(-117.6%)
-$411.80 K(-17.6%)
Dec 2023
-$500.00 K(<-9900.0%)
-$500.00 K(<-9900.0%)
-$500.00 K(<-9900.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2022
$0.00(-100.0%)
-
-
Dec 2021
-$10.32 M(<-9900.0%)
-$10.25 M(<-9900.0%)
-$10.32 M(<-9900.0%)
Sep 2021
-
$2500.00(-103.4%)
$18.80 K(+15.3%)
Jun 2021
-
-$73.90 K(-181.9%)
$16.30 K(-81.4%)
Dec 2020
$87.30 K(-462.2%)
$90.20 K(>+9900.0%)
$87.40 K(-1001.0%)
Sep 2020
-
$0.00(-100.0%)
-$9700.00(-28.7%)
Jun 2020
-
$1500.00(-134.9%)
-$13.60 K(-9.9%)
Mar 2020
-
-$4300.00(-37.7%)
-$15.10 K(-37.6%)
Dec 2019
-$24.10 K
-$6900.00(+76.9%)
-$24.20 K(-91.2%)
Sep 2019
-
-$3900.00(<-9900.0%)
-$274.40 K(-1.2%)
DateAnnualQuarterlyTTM
Jun 2019
-
$0.00(-100.0%)
-$277.80 K(-4.0%)
Mar 2019
-
-$13.40 K(-94.8%)
-$289.30 K(-5.3%)
Dec 2018
-$305.50 K(+848.8%)
-$257.10 K(+3421.9%)
-$305.40 K(+529.7%)
Sep 2018
-
-$7300.00(-36.5%)
-$48.50 K(-6.6%)
Jun 2018
-
-$11.50 K(-61.0%)
-$51.90 K(-15.1%)
Mar 2018
-
-$29.50 K(>+9900.0%)
-$61.10 K(+89.8%)
Dec 2017
-$32.20 K(+159.7%)
-$200.00(-98.1%)
-$32.20 K(+3.2%)
Sep 2017
-
-$10.70 K(-48.3%)
-$31.20 K(+41.8%)
Jun 2017
-
-$20.70 K(+3350.0%)
-$22.00 K(+83.3%)
Mar 2017
-
-$600.00(-175.0%)
-$12.00 K(-2.4%)
Dec 2016
-$12.40 K(-49.2%)
$800.00(-153.3%)
-$12.30 K(-30.1%)
Sep 2016
-
-$1500.00(-86.0%)
-$17.60 K(-23.1%)
Jun 2016
-
-$10.70 K(+1088.9%)
-$22.90 K(+60.1%)
Mar 2016
-
-$900.00(-80.0%)
-$14.30 K(-41.4%)
Dec 2015
-$24.40 K
-$4500.00(-33.8%)
-$24.40 K(+22.6%)
Sep 2015
-
-$6800.00(+223.8%)
-$19.90 K(+51.9%)
Jun 2015
-
-$2100.00(-80.9%)
-$13.10 K(+19.1%)
Mar 2015
-
-$11.00 K
-$11.00 K

FAQ

  • What is Entero Therapeutics annual cash flow from investing activities?
  • What is the all time high annual CFI for Entero Therapeutics?
  • What is Entero Therapeutics annual CFI year-on-year change?
  • What is Entero Therapeutics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Entero Therapeutics?
  • What is Entero Therapeutics quarterly CFI year-on-year change?
  • What is Entero Therapeutics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Entero Therapeutics?
  • What is Entero Therapeutics TTM CFI year-on-year change?

What is Entero Therapeutics annual cash flow from investing activities?

The current annual CFI of ENTO is -$500.00 K

What is the all time high annual CFI for Entero Therapeutics?

Entero Therapeutics all-time high annual cash flow from investing activities is $87.30 K

What is Entero Therapeutics annual CFI year-on-year change?

Over the past year, ENTO annual cash flow from investing activities has changed by -$500.00 K (-100.00%)

What is Entero Therapeutics quarterly cash flow from investing activities?

The current quarterly CFI of ENTO is $0.00

What is the all time high quarterly CFI for Entero Therapeutics?

Entero Therapeutics all-time high quarterly cash flow from investing activities is $90.20 K

What is Entero Therapeutics quarterly CFI year-on-year change?

Over the past year, ENTO quarterly cash flow from investing activities has changed by +$500.00 K (+100.00%)

What is Entero Therapeutics TTM cash flow from investing activities?

The current TTM CFI of ENTO is -$411.80 K

What is the all time high TTM CFI for Entero Therapeutics?

Entero Therapeutics all-time high TTM cash flow from investing activities is $87.40 K

What is Entero Therapeutics TTM CFI year-on-year change?

Over the past year, ENTO TTM cash flow from investing activities has changed by +$88.20 K (+17.64%)